January 2026
The global investigational new drug CDMO market size is estimated to hit around USD 10.90 billion by 2035 from USD 5.61 billion in 2025, with a CAGR of 6.87%.
April 2026
The global chemical drug CDMO market size was evaluated at USD 13.20 billion in 2025 and is predicted to hit around USD 29.84 billion by 2035, growing at a CAGR of 8.50%.
March 2026
The hormonal drug CDMO market is expanding with rising demand for outsourced development and manufacturing of therapies for endocrine and reproductive health.
September 2025
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
June 2025
The global topical drugs CDMO market size was exhibited at USD 46.62 billion in 2024 and is predicted to surpass around USD 136.39 billion by 2034, with a CAGR of 11.33%.
June 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
August 2025
The U.S. pharmaceutical CDMO market size was calculated at USD 40.52 billion in 2024 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
July 2025
The global adrenoleukodystrophy drugs market size was evaluated at USD 519.45 million in 2024 and is predicted to hit around USD 1,915.60 billion by 2034, at a CAGR of 13.94%.
July 2026
Explore the dimethyl ether (DME) and renewable DME (rDME) market, driven by clean fuel adoption, zero-emission mandates, and innovations in renewable feedstock technologies.
July 2026
Explore the checkpoint inhibitor drugs market, driven by rising cancer prevalence, expanding indications for PD-1/PD-L1 and CTLA-4 inhibitors, and advancements in immuno-oncology therapies.
July 2026
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
July 2026
The global renewable energy market size is predicted to hit around USD 8.25 trillion by 2035, rising from USD 1.74 trillion in 2025, growing at a CAGR of 16.84%.
July 2026
The next?gen delivery systems for genetic drug market is expanding with lipid nanoparticles, viral vectors, and extracellular vesicles enabling precision gene delivery.
July 2026
The global AI-powered drug formulation market is growing as pharmaceutical companies leverage AI to optimize drug design, delivery, and efficacy.
July 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
July 2026
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
June 2026
The global renewable energy integration services market accelerates due to clean energy growth, grid optimization needs, and real-time renewable management solutions.
June 2026
The global epigenetic drugs market size is anticipated at USD 16.22 billion in 2025 and is predicted to hit around USD 92.57 billion by 2035, growing at a CAGR of 19.03%.
June 2026
The global small molecule innovator CDMO market size is valued at USD 56.41 billion in 2025 and is projected to hit around USD 103.22 billion by 2035 with a CAGR of 6.23%.
June 2026
The global sterile injectables CDMO market size is estimated to hit around USD 11.82 billion by 2035 from USD 4.73 billion in 2025, with a CAGR of 9.59%.
June 2026
The drug discovery services market size was estimated at USD 24.26 billion in 2025 and is expected to hit around USD 89.58 billion by 2035, growing at a CAGR of 13.95% from 2026 to 2035.
June 2026
The global drug discovery outsourcing market size was valued at USD 4.45 billion in 2025 and is projected to hit around USD 8.98 billion by 2035 with a CAGR of 7.27%.
June 2026
The global topical drug delivery market size was valued at USD 136.35 billion in 2025 and is expected to hit around USD 324.67 billion by 2035, growing at a CAGR of 9.06%.
June 2026
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 18.43 billion by 2035 increasing from USD 8.44 billion in 2025, with a CAGR of 8.12%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
The global rheumatoid arthritis drugs market size was valued at USD 64.35 billion in 2025 and is expected to hit around USD 76.83 billion by 2035, growing at a CAGR of 1.79% from 2026 to 2035.
June 2026
The global sarcoidosis drug market size was estimated at USD 8.82 billion in 2025 and is expected to hit around USD 15.93 billion by 2035, growing at a CAGR of 6.09%.
June 2026
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
June 2026
The global lyophilized oncology drug market size is growing as demand increases for stable, long-lasting cancer formulations and advanced freeze-drying technologies.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com